journal article·2023-12

Poly‐ε‐caprolactone (PCL)/poly‐l‐lactic acid (PLLA) nanofibers loaded by nanoparticles‐containing TGF‐β1 with linearly arranged transforming structure as a scaffold in cartilage tissue engineering

Elham Kalvand, Haleh Bakhshandeh, Samad Nadri, Mina Habibizadeh, Kobra Rostamizadeh

Publisher page

Abstract

Abstract This study aimed to present a novel three‐dimensional nanocomposite scaffold using poly‐ε‐caprolactone (PCL), containing transforming growth factor‐beta 1 (TGF‐β1)‐loaded chitosan‐dextran nanoparticles and poly‐l‐lactic acid (PLLA), to make use of nanofibers and nanoparticles simultaneously. The electrospinning method fabricated a bead‐free semi‐aligned nanofiber composed of PLLA, PCL, and chitosan‐dextran nanoparticles containing TGF‐β1. A biomimetic scaffold was constructed with the desired mechanical properties, high hydrophilicity, and high porosity. Transmission electron microscopy findings showed a linear arrangement of nanoparticles along the core of fibers. Based on the results, burst release was not observed. The maximum release was achieved within 4 days, and sustained release was up to 21 days. The qRT‐PCR results indicated an increase in the expression of aggrecan and collagen type Ι genes compared to the tissue culture polystyrene group. The results indicated the importance of topography and the sustained release of TGF‐β1 from bifunctional scaffolds in directing the stem cell fate in cartilage tissue engineering.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Periodontal Regeneration and Treatments · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Biomaterials, School of Pharmacy Zanjan University of Medical Sciences Zanjan Iran

Department of Nanobiotechnology Pasteur Institute of Tehran Tehran Iran

Department of Nanotechnology and Tissue Engineering Stem Cell Technology Research of Tehran Tehran Iran

New Technologies Research Group, Department of Nanobiotechnology Pasteur Institute of Iran Tehran Iran

Zanjan Pharmaceutical Nanotechnology Research Center Zanjan University of Medical Sciences Zanjan Iran

Department of Medical Nanotechnology, School of Medicine Zanjan University of Medical Sciences Zanjan Iran

Regenerative Medicine Research Center Kermanshah University of Medical Sciences Kermanshah Iran

Pharmaceutical Biomaterials Department, School of Pharmacy Zanjan University of Medical Sciences Zanjan Iran

Funding

Zanjan University of Medical Sciences

References (52)

Show source-provided references
1. 10.3389/fbioe.2021.60344410.3389/fbioe.2021.603444 ↗
2. 10.1155/2014/74092610.1155/2014/740926 ↗
3. 10.1039/C6BM00068A10.1039/C6BM00068A ↗
4. 10.1007/s13205-020-2134-510.1007/s13205-020-2134-5 ↗
5. 10.3390/cells1003064310.3390/cells10030643 ↗
6. 10.1007/s11999-011-1857-310.1007/s11999-011-1857-3 ↗
7. 10.1016/j.ejpb.2010.12.00110.1016/j.ejpb.2010.12.001 ↗
8. 10.1002/jps.2141210.1002/jps.21412 ↗
9. 10.1021/bm061211k10.1021/bm061211k ↗
10. 10.1371/journal.pone.005819810.1371/journal.pone.0058198 ↗
11. 10.1002/sctm.16-027110.1002/sctm.16-0271 ↗
12. 10.22203/eCM.v036a0810.22203/eCM.v036a08 ↗
13. 10.3390/membranes1011034810.3390/membranes10110348 ↗
14. 10.1002/jbm.a.3568610.1002/jbm.a.35686 ↗
15. 10.1371/journal.pone.010700110.1371/journal.pone.0107001 ↗
16. 10.1002/jbm.a.3320610.1002/jbm.a.33206 ↗
17. 10.1007/s10989-004-2433-410.1007/s10989-004-2433-4 ↗
18. 10.1016/j.eurpolymj.2008.04.03310.1016/j.eurpolymj.2008.04.033 ↗
19. 10.1016/j.eurpolymj.2014.10.01710.1016/j.eurpolymj.2014.10.017 ↗
20. 10.1016/j.carbpol.2017.03.08210.1016/j.carbpol.2017.03.082 ↗
21. 10.1016/j.procir.2015.11.01910.1016/j.procir.2015.11.019 ↗
22. 10.1016/j.tice.2016.11.00110.1016/j.tice.2016.11.001 ↗
23. 10.1016/j.bioactmat.2017.05.00310.1016/j.bioactmat.2017.05.003 ↗
24. 10.1016/j.ijbiomac.2015.01.05110.1016/j.ijbiomac.2015.01.051 ↗
25. Current state of cartilage tissue engineering using nanofibrous scaffolds and stem cells
26. 10.1016/j.ejpb.2013.06.00210.1016/j.ejpb.2013.06.002 ↗
27. 10.3390/polym1003023510.3390/polym10030235 ↗
28. Optimized preparation of lysozyme loaded dextran‐chitosan nanoparticles using D‐optimal design
29. 10.1016/j.onano.2017.04.00210.1016/j.onano.2017.04.002 ↗
30. 10.1016/j.ijbiomac.2011.07.00610.1016/j.ijbiomac.2011.07.006 ↗
31. 10.1016/j.carbpol.2011.01.00510.1016/j.carbpol.2011.01.005 ↗
32. 10.1016/j.polymer.2012.10.03210.1016/j.polymer.2012.10.032 ↗
33. Poly (ε‐caprolactone) nanofibrous ring surrounding a polyvinyl alcohol hydrogel for the development of a biocompatible two‐part artificial cornea
34. 10.1007/s00441-011-1243-110.1007/s00441-011-1243-1 ↗
35. 10.1016/j.actbio.2011.09.03710.1016/j.actbio.2011.09.037 ↗
36. 10.1016/j.colsurfb.2014.11.00310.1016/j.colsurfb.2014.11.003 ↗
37. 10.1016/j.biomaterials.2010.02.02810.1016/j.biomaterials.2010.02.028 ↗
38. Characterization of wet‐electrospun poly (ε‐caprolactone)/poly (l‐lactic) acid with calcium phosphates coated with chitosan for bone engineering
39. 10.1089/ten.teb.2018.011910.1089/ten.teb.2018.0119 ↗
40. 10.1016/j.ijpharm.2016.09.04410.1016/j.ijpharm.2016.09.044 ↗
41. 10.1007/s13770-016-9083-410.1007/s13770-016-9083-4 ↗
42. 10.1016/j.jbiosc.2011.12.00910.1016/j.jbiosc.2011.12.009 ↗
43. 10.1016/j.ijbiomac.2020.12.12510.1016/j.ijbiomac.2020.12.125 ↗
44. 10.1002/jbm.a.3720810.1002/jbm.a.37208 ↗
45. 10.22203/eCM.v023a0610.22203/eCM.v023a06 ↗
46. 10.1098/rsif.2010.022310.1098/rsif.2010.0223 ↗
47. 10.1016/j.bbagen.2014.02.03010.1016/j.bbagen.2014.02.030 ↗
48. 10.1186/scrt11310.1186/scrt113 ↗
49. 10.5483/BMBRep.2016.49.10.07110.5483/BMBRep.2016.49.10.071 ↗
50. 10.6061/clinics/2012(02)0310.6061/clinics/2012(02)03 ↗
51. 10.1186/ar426010.1186/ar4260 ↗
52. Expression of collagen type I and II, aggrecan and SOX9 genes in mesenchymal stem cells on different bioscaffolds